repurposing semaglutide and liraglutide for alcohol use disorder Weight‐loss drugs improve outcomes in patients GLP-1s Could Help Reduce Alcohol
Description
After 6 weeks of treatment, a reduction in PASI score was observed, along with an increase in circulating invariant Natural Killer (iNK) T cells and a decrease in their number within the psoriatic plaque
This mechanism is the same across all injectable medications, from insulin to biologics, and occurs independently of the drug's active ingredients
The importance of providing comprehensive education to individuals with T2D is established
Long-term follow-up data shows these improvements persist for months after reaching therapeutic doses, providing durable metabolic benefits
